Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Mar 25.
Published in final edited form as: Chem Biol Interact. 2012 Oct 6;203(1):38–43. doi: 10.1016/j.cbi.2012.09.017

Hydrolysis of low concentrations of the acetylthiocholine analogs acetyl(homo)thiocholine and acetyl(nor)thiocholine by acetylcholinesterase may be limited by selective gating at the enzyme peripheral site

Veena Beri 1, Jeffrey T Auletta 1,1, Ghulam M Maharvi 1, Juanita F Wood 1, Abdul H Fauq 1, Terrone L Rosenberry 1
PMCID: PMC3586822  NIHMSID: NIHMS419963  PMID: 23047027

Abstract

Hydrolysis of acetylcholine by acetylcholinesterase (AChE) is extremely rapid, with a second-order hydrolysis rate constant kE (often denoted kcat/KM) that approaches 108 M−1s−1. AChE contains a deep active site gorge with two sites of ligand binding, an acylation site (or A-site) containing the catalytic triad at the base of the gorge and a peripheral site (or P-site) near the gorge entrance. The P-site is known to contribute to catalytic efficiency with acetylthiocholine (AcSCh) by transiently trapping the substrate in a low affinity complex on its way to the A-site, where a short-lived acyl enzyme intermediate is produced. Here we ask whether the P-site does more than simply trap the substrate but in fact selectively gates entry to the A-site to provide specificity for AcSCh (and acetylcholine) relative to the close structural analogs acetylhomothiocholine (Ac-hSCh, which adds one additional methylene group to thiocholine) and acetylnorthiocholine (Ac-nSCh, which deletes one methylene group from thiocholine). We synthesized Ac-hSCh and Ac-nSCh and overcame technical difficulties associated with instability of the northiocholine hydrolysis product. We then compared the catalytic parameters of these substrates with AChE to those of AcSCh. Values of kE for Ac-hSCh and Ac-nSCh were about 2% of that for AcSCh. The kE for AcSCh is close to the theoretical diffusion-controlled limit for the substrate association rate constant, but kE values for Ac-hSCh or Ac-nSCh are too low to be limited by diffusion control. However, analyses of kinetic solvent isotope effects and inhibition patterns for P-site inhibitors indicate that these two analogs also do not equilibrate with the A-site prior to the initial acylation step of catalysis. We propose that kE for these substrates is partially rate-limited by a gating step that involves the movement of bound substrate from the P-site to the A-site.

Keywords: Acetylcholinesterase, peripheral site, active site gating, acetylthiocholine analogs, thioflavin T, enzyme mechanism

1. Introduction

A better understanding of the AChE catalytic pathway may identify new mechanistic opportunities for AChE inhibition that could be therapeutically beneficial. Kinetic and thermodynamic studies have revealed that substrates and inhibitors can interact with either or both of two binding sites in AChE (14), and X-ray crystallography has provided information about the location of these sites (58). A narrow active site gorge some 20 Å deep penetrates nearly to the center of the ~65 kDa catalytic subunits. Near the base of the gorge is the acylation or A-site where H447, E334, and S203 2 ) participate in a triad that catalyzes the transient acylation and deacylation of S203 during each substrate turnover. The peripheral or P-site, spanned by residues W286 near the mouth of the gorge and D74 near a constriction at the boundary between the P-site and the A-site, specifically binds certain ligands like the neurotoxin fasciculin (9, 10) and the fluorescent probes propidium (2) and thioflavin T (3, 7). The P-site thus far has been shown to contribute to catalytic efficiency by insuring that most substrate molecules that collide with and transiently bind to the P-site proceed on to the A-site (1113) and, with certain bound cationic substrates, by providing a modest allosteric activation of the acylation step (14). Here we ask whether the P-site does more than simply trap the substrate but in fact selectively gates entry to the A-site to provide specificity for AcSCh (and acetylcholine) relative to the close structural analogs acetyl(homo)thiocholine (Ac-homoSCh, which adds one additional methylene group to thiocholine) and acetyl(nor)thiocholine (Ac-norSCh, which deletes one methylene group from thiocholine) (Fig. 1).

Fig. 1.

Fig. 1

AChE substrates, and thioflavin T, an inhibitor of AChE.

2. Experimental methods

2.1. Synthesis of 3-(acetylthio)-N,N,N-trimethylpropanaminium iodide (Ac-homoTCh)

Thiolacetic acid (5.68 mL, 79.0 mmol) was added to a solution of 3-(dimethylamino)propyl chloride hydrochloride (10.0 g, 63.3 mmol) in N,N-dimethylformamide (135 mL). This was followed by portionwise addition of cesium carbonate (51.5 g, 158 mmol). The resulting suspension was stirred under nitrogen for 10 min and then heated to 70° C in an oil bath overnight. After cooling to room temperature, water (300 mL) was added and the reaction mixture was poured into a separatory funnel and extracted with ether (4 × 100 mL). The combined organic extracts were washed with water, dried over MgSO4, filtered, and concentrated in vacuo to afford the product, S-3-(dimethylamino)propyl ethanethioate (I), as a light yellow oil: Yield 10.1 g (99%). This material was used in the next step without further purification. 1H NMR (CDCl3, 300 MHz) δ 2.90 (t, 2H, J = 7.2 Hz), 2.32 (m, 2H), 2.21 (s, 6H), 1.74 (m, 2H). MS m/z (ESI) 162.16 (M+1)+.

Compound I (9.0 g, 56 mmol) in diethyl ether (295 mL) was placed in a clean, dry round bottom flask containing sodium carbonate (8.87 g, 84.0 mmol). The solution was stirred and iodomethane (17.45 mL, 279.0 mmol) was slowly introduced to the resulting suspension at room temperature under nitrogen. The flask was covered with a black cloth and the reaction was allowed to proceed in the dark overnight. During this time, a solid precipitated that was separated by filtration. Drying of this solid produced a lumpy material that was pressed into a fine powder. This powder was first washed with a (1:1) mixture of diethyl ether and hexane, and then thoroughly leached and extracted with several fresh portions of dichloromethane. The combined dichloromethane fractions were evaporated under reduced pressure to afford a light brownish solid that was dissolved in water and decolorized by stirring with activated carbon for 30 min at 25 °C. The product Ac-homoTCh was filtered through Celite and lyophilized. The residue was further purified by recrystallization with dichloromethane to afford a white solid: Yield 13.5 g (80%). 1H NMR (CDCl3, 300 MHz) δ 3.74 (m, 2H), 3.46 (s, 9H), 3.00 (t, 2H, J = 6.9 Hz), 2.39 (s, 3H), 2.12 (m, 2H). MS m/z (ESI) 176.32 (M+)+.

2.2. Synthesis of 1-(acetylthio)-N,N,N-trimethylmethanaminium iodide (Ac-norSCh)

N-methyl-N-methylenemethanaminium chloride (3.00 g, 32.1 mmol) and potassium thioacetate (4.39 g, 38.5 mmol) were suspended in diethyl ether (33 mL) and stirred under nitrogen overnight. After filtering through Celite, the filtrate was concentrated in vacuo to afford the adduct, S-(dimethylamino)methyl ethanethioate (II), as a light yellow oil: Yield 3.75 g (88%). This material was carried to the next step without further purification. 1H NMR (CDCl3, 300 MHz) δ 4.56 (s, 2H), 2.40 (s, 3H), 2.22 (s, 6H). MS m/z (ESI) 134.19 (M+1)+.

Iodomethane (14.55 mL, 233.0 mmol) was added to a solution of II (6.2 g, 46.5 mmol) in diethyl ether (243 mL). Sodium carbonate (7.40 g, 69.8 mmol) was added portionwise. The flask was covered with a black cloth and the turbid suspension was stirred under nitrogen at room temperature overnight. The precipitated solid generated during the reaction was filtered and washed with a 1:1 mixture of diethyl ether and hexanes. The residue was scraped with a spatula and leached with several portions of dry dichloromethane. The combined dichloromethane extracts were filtered and evaporated under reduced pressure to furnish the product as a light brownish solid. Double recrystallization, first with isopropanol and then with dichloromethane, furnished a white solid that was judged pure by 1H NMR. Yield 8.20 g (64%). 1H NMR (CDCl3, 300 MHz) δ 5.2 (s, 2H), 3.46 (s, 9H), 2.57 (s, 2H). MS m/z (ESI) 148.21 (M)+.

2.3. Assays of substrate hydrolysis

Recombinant human AChE was expressed as a secreted, disulfide-linked dimer in Drosophila S2 cells and purified as outlined previously (15). Thioflavin T (Sigma) was recrystallized from water, and concentrations were assigned by absorbance at 412 nm with ε412 nm = 36,000 M−1cm−1. For AcSCh and the two new thioester substrates, the hydrolysis rates v were measured in a coupled Ellman reaction in which the thiol generated in the presence of 5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB) (2.0 mM unless otherwise noted) was determined by formation of the thiolate dianion of DTNB from the absorbance (A) at 412 nm (Δε412 nm = 14,150 M−1cm−1) (14). Total AChE concentrations (Etot) were calculated assuming 450 units/nmol (which, under the assay conditions here, corresponds to 4.8 ΔA412/min with 0.5 mM acetylthiocholine substrate and 1 nM AChE) (3). Assays were conducted at 25° C in 20 mM sodium phosphate buffer (pH 7.0) and 0.01% bovine serum albumin (BSA) (assay buffer), and to maintain constant ionic strength NaCl was added so that the sum of the substrate and NaCl concentrations was 60 mM. AChE concentrations were varied to optimize measured rates, and non-enzymatic hydrolysis rates were deducted from all enzymatic hydrolysis rates.

2.4. Kinetic analysis of substrate hydrolysis rates

When the concentration of substrate (S) is low ([S] ≪ KD, where KD is defined in Eq. (2) below), the most accurate way to measure the AChE-catalyzed second-order hydrolysis rate constant kE is from Eq. (1) (16).

[S]=[S]0e-zt (1)

In Eq. (1), z = kE[E]tot, where t is the time after initial mixing of enzyme (E) and S at t = 0. To fit hydrolysis data, the following substitutions were made in Eq. (1) and the equation was solved for A412 at time t: [S] = (A412 − A412(final))/Δε412 nm, where A412(final) is A412 at the conclusion of the exponential time course; and [S]0 = (A412(final)A412(t=0))/Δε412 nm.

When an inhibitor specific for the P-site is present during second order substrate hydrolysis (e.g., Scheme 1 below), the ratio of kE in the absence of inhibitor (kE [I]=0) to kE in the presence of inhibitor (kE +I) can be fitted to Eq. (2) (16, 17).

Scheme 1.

Scheme 1

kE[I]=0kE+I=(1+[I]KI)(1+α[I]KI) (2)

The fitted parameter α can be interpreted in mechanistic terms regardless of whether the substrate equilibrates with the enzyme (16).

Over a wider range of [S], AChE-catalyzed hydrolysis of several substrates has been shown to deviate from classical hyperbolic Michaelis-Menten kinetics (14). Eq. (3) includes terms that can account for these deviations.

v[E]tot=kE[S]·(1+aSA[S]KSA)(1+aSI[S]KSI)(1+[S]KD)(1+[S]KSA)(1+[S]KSI) (3)

In addition to a term representing the active site where hydrolysis occurs (with apparent substrate dissociation constant KD), it includes a substrate inhibition site (with apparent dissociation constant KSI), and a substrate activation site (with apparent dissociation constant KSA) (18). Binding of substrate to the inhibition site decreases substrate turnover (aSI < 1) while binding of substrate to the activation site increases substrate turnover (aSA > 1). When substrates fully equilibrate with AChE, these apparent dissociation constants can represent actual thermodynamic binding (e.g., KD is the Michaelis constant KM). However, some substrates proceed through the catalytic pathway too fast to equilibrate with AChE, and in this case Eq. (3) simply offers an empirical fit that allows detection of substrate inhibition or activation without a mechanistic context (14). After assigning aSI as zero and fixing kE at the value measured with Eq. (1), data were fitted to Eq. (2) by nonlinear regression with SigmaPlot (vers.11.0) to obtain fitted values of KD, KSI, KSA, and aSA.

3. Results and Discussion

3.1. Stability of Ac-homoSCh, Ac-norSCh, and the hydrolysis product northiocholine (norSCh)

The AChE substrates Ac-homoSCh and Ac-norSCh (Fig. 1) were synthesized as outlined in the Experimental methods. Non-enzymatic hydrolysis rate constants (knonE) for AcSCh and Ac-homoSCh were almost negligible at the AChE concentrations employed (knonE values were 16 × 10−6 and 8 × 10−6 mM−1min−1, respectively). However, knonE for Ac-norSCh was much larger (700 × 10−6 mM−1min−1), as expected from the electron withdrawing effect of the quaternary ammonium group on the stability of the thioester bond, and this knonE became quite significant at the highest substrate concentrations examined in this report. For example, at 50 mM Ac-norSCh, the non-enzymatic hydrolysis rate vnonE was about 0.5 ΔA412/min in our assay. As a further complication, this rate at high concentrations of Ac-norSCh was not linear but rapidly decreased: vnonE decreased 26% over one minute with 50 mM Ac-norSCh, in contrast to a decrease of < 3% over one minute with 5 mM Ac-norSCh. Mass spectrometry analysis of an aqueous dilution of Ac-norSCh in assay buffer revealed that the hydrolysis product northiocholine (norSCh: (CH3)3N+-CH2-SH) was not stable but proceeded along two additional reaction pathways. The first pathway generated trimethylamine (CH3)3N, (M+1)+ 60) and was inferred to be a decomposition of norSCh that produced trimethylamine, formaldehyde, and hydrogen sulfide. The second pathway produced 1-((3-mercaptopropanoyl)thio)-N,N,N-trimethylmethanaminium (CH3)3N+-CH2-S-CO-(CH2)2-SH, (M)+ 194), and this product can be generated by an irreversible nucleophilic displacement of trimethylamine from norSCh by the enolate tautomer of Ac-norSCh. With 50 mM Ac-norSCh in assay buffer, the second pathway was predominant over the first, but addition of 2 mM DTNB to this mixture decreased the 194 (M)+ ion peak by more than a factor of two. These observations indicated that Ac-norSCh and DTNB compete for reaction with norSCh and that this competition will reduce the rate of formation of the chromophoric reporter group, the thiolate dianion of DTNB.

To minimize the distorting effect of high concentrations of Ac-norSCh on its nonenzymatic and enzymatic hydrolysis rates measured with DTNB, we took three steps. First, stock Ac-norSCh was weighed individually (≥2 mg) for each assay above 20 μM Ac-norSCh and assayed within three minutes after initial dissolution in water and 10-fold dilution into assay buffer. Although this tedious precaution decreased the precision of each assay and contributed to scatter of the data over a range of substrate concentrations, it substantially improved the reproducibility of hydrolysis rates at substrate concentrations > 5 mM. Second, initial rate measurements at concentrations of Ac-norSCh > 5 mM were limited to the first minute after mixing. Third, the DTNB concentration in assays was increased from the conventional 0.33 mM to 2 mM. This change alone increased ΔA412/min 2-fold at 50 mM Ac-norSCh, as might be expected if Ac-norSCh and DTNB compete for reaction with the norSCh hydrolysis product. These steps appeared to eliminate the distorting effects of high concentrations of Ac-norSCh, as vnonE was observed to increase linearly with Ac-norSCh concentration up to 50 mM.

3.2. Ac-homoSCh and Ac-norSCh are hydrolyzed much more slowly than AcSCh by AChE

AChE-catalyzed hydrolysis rates for all three substrates were fitted to Eq. (3) (Fig. 2), and the fitted parameters for Ac-homoSCh and Ac-norSCh are compared to those for AcSCh in Table 1. Second order hydrolysis rate constants kE were similar for Ac-homoSCh and Ac-norSCh and about 60-fold smaller than the kE for AcSCh. Maximal normalized hydrolysis rates v/[E]tot for Ac-homoSCh and Ac-norSCh were about 5- and 8-fold smaller, respectively, than that for AcSCh. The data indicated that none of the three substrates followed classical Michaelis-Menten kinetics. All showed a substrate inhibition component, although its magnitude with Ac-norSCh was uncertain because of the technical problems noted above in assaying this substrate at concentrations greater than 5 mM. Ac-homoSCh also exhibited substrate activation. Values of kE and KD for AcSCh were about 30% larger and 30% smaller, respectively, than previously reported (14). These differences largely resulted from the substitution of 0.01% BSA for 0.02% Triton X-100 to stabilize AChE activity. Triton X-100 has been observed to inhibit the activity of insect and eel AChEs (19, 20), and we found that 0.01% BSA was better than 0.02% Triton X-100 at stabilizing dilute AChE activity over periods of several hours. The value of the substrate activation parameter aSA (3.1) obtained for Ac-homoSCh is comparable to that previously observed for the cationic acetanilide ATMA and for AcSCh with the human W86A mutant (14). AcSCh exhibits only barely detectable substrate activation with wild type human AChE, probably because the acetylation step is not rate limiting (14).

Fig. 2.

Fig. 2

(A) Hydrolysis rates for the three indicated substrates of AChE were normalized by the total AChE concentration (v/[E]tot) and plotted against the substrate concentration. Plots were fitted to Eq. 3 as outlined in Table 1 to obtain kinetic parameters. (B) Data for Ac-homoSCh and Ac-norSCh in panel A are shown in expanded form. (C) and (D) Experimental points and fitted curves in panel B were transformed to the Eadie-Hofstee format (23) in panel C to clarify the observation of substrate activation for Ac-homoSCh, where points to the right of the maximal v/[E]tot are concave upward. Intercepts on the x-axes correspond to values of kE, which were known with great precision (Table 1).

Table 1.

Analysis of substrate hydrolysis according to the three-site model in Eq. (3).

Substrate kE mM−1s−1 aSA KSA mM KSI mM KD mM
AcSCh (102 ± 4) × 103 b b 16 ± 1 0.057 ± 0.005
Ac-homoSCh 1650 ± 70 3.1 ± 0.2 5.1 ± 1.1 107 ± 17 0.33 ± 0.03
Ac-norSCh 1540 ± 60 b b 65 ± 20 0.47 ± 0.03

Values of kE were obtained by fitting second order hydrolysis rates with Eq. (1) (the number n of independent kE measurements for each substrate was 4 – 7). Substrate hydrolysis profiles like those in Fig. 2 were then fitted to eq. 3 with kE fixed to obtain the three equilibrium constants KSA, KSI and KD and the relative acceleration constant aSA (n was 3 for Ac-homoSCh and 1 for AcSCh and Ac-norSCh).

b

With AcSCh and Ac-norSCh, no substrate activation phase was apparent and KSA−1 was fixed at zero for fitting, removing aSA as a variable. For these two substrates, standard errors were calculated from the fitting procedure.

3.3. Do the low values of kE for Ac-homoSCh and Ac-norSCh relative to kE for AcSCh reveal that their entry to the A-site is partially limited by gating at the P-site?

Here we return to the question of whether the P-site does more than simply trap the substrate but in fact selectively gates entry to the A-site to provide specificity for AcSCh (and acetylcholine) relative to the close structural analogs Ac-homoSCh and Ac-norSCh. To define gating in enzyme kinetics terms, a model of the AChE catalytic pathway is required. This pathway for AcSCh is known to include acetyl enzyme intermediates in addition to the initial enzyme-substrate complexes (12, 13). Under second-order substrate hydrolysis conditions, however, ternary complexes involving two S molecules bound to E as well as all downstream acetylated intermediates become negligible because [S] approaches zero. In this case, Scheme 1 offers an appropriate reaction model (16).

This scheme involves two enzyme substrate intermediates, ESP at the P-site and ES at the A-site, in addition to free enzyme E. An additional ligand specific to the P-site (IP) is also included, and in the ternary complex ESIP the acylation rate constant k2 can be increased or decreased by the factor aI. In the context of Scheme 1, the second-order rate constant kE in the absence of I is given by Eq. (4).

kE=kSk1k2k-Sk-1+k2(k-S+k1) (4)

As emphasized by Quinn (21), the rate constant kE monitors conversion of free enzyme and free substrate to a transition state(s) in the acylation stage of catalysis, and it incorporates all initial reversible steps in the pathway up to the first irreversible step. The value of kE can be limited by any of the three forward steps in Scheme 1. Under equilibrium conditions (where the bond-breaking step k2 is much smaller than simple binding steps like k−1), kE = k2/KM, where KM = KSK1 (KS = k−S/kS and K1 = k−1/k1), and k2 is rate limiting. The binding steps that comprise KM cannot be determined individually. Because of the strength of their ester or amide bonds, many carbamate and acetanilide substrates of AChE fall into this category (16). At the other extreme, the forward steps may be so much faster than the reverse steps that they become irreversible (k2k−1 and k1k−S), and then kE = kS, the substrate association rate constant. This is thought to be the case with AcSCh (13), as its kE of 108 M−1s−1 (Table 1) is close to the expected diffusion-controlled value for kS. In this case also, the binding steps that comprise KM cannot be determined individually. In Scheme 1, k1 is the rate constant at which S moves from the P-site to the A-site, and we interpret k1 as a gating rate constant for S entry to the A-site. For k1 to be rate limiting, k−S must be ≫ k1 but k2k−1. This gives kE = k1/KS.

Some information is available about rate constants that comprise KM. Competitive binding experiments with fasciculin 2 and AcSCh (12) or thioflavin T and Ac-homoSCh or Ac-norSCh3 indicate that KS for all three substrates is around 1 mM. Assuming that all have similar kS values that reach or exceed the near diffusion-controlled limit noted above for AcSCh, these substrates would have k−S values ≥ 105 s−1 for their dissociation from the AChE P-site. Based on the arguments above and the kE for AcSCh in Table 1, this value implies that the gating rate constant k1 for AcSCh must be ≥ 105 s−1. By the same arguments, the 60-fold lower values of kE for Ac-homoSCh or Ac-norSCh in Table 1 rule out kS being rate-limiting for these substrates and leave k1 or k2 as the possible rate-limiting steps for kE. In this case, k−Sk1 and kE in Eq. 4 reduces to the expression in Eq. (5).

kE=k1k2KS(k-1+k2) (5)

Two additional experiments argue that k2 is itself not rate-limiting and that k1 contributes to rate limitation of kE. The first measured solvent deuterium oxide (D2O) isotope effects, which can identify enzyme-catalyzed steps that are rate-limited by proton transfer (21). With AChE, kcat is a measure of the turnover rate at high [S] and is primarily determined by rate constants like k2 that involve proton transfer. For acetylthiocholine and phenyl acetate, kcat was slowed by factors of 2.03 ± 0.05 and 2.45 ± 0.08, respectively, when H2O was replaced by D2O (22), values typical of enzyme-catalyzed acyl transfer reactions. In contrast, kE was slowed by factors of only 1.21 ± 0.02 and 1.48 ± 0.05, respectively, indicating that kE was limited primarily by steps before k2. The D2O isotope effects on kE for Ac-homoSCh or Ac-norSCh were 1.59 ± 0.05 and 1.81 ± 0.03, respectively 3 , a range that indicates only partial rate determination by a proton transfer step.

The second experiment examined inhibition of AChE hydrolysis at low [S] by the P-site inhibitor thioflavin T (Fig. 3). Particular attention was given to the parameter α (see Eq. (2)), the ratio of kE +I to kE [I]=0 at saturating concentrations of inhibitor. Previous studies have found that kE values for slowly hydrolyzed substrates which equilibrate with AChE, like carbachol and ATMA, are unaffected by bound inhibitor (α = 1) (16), while rapidly hydrolyzed substrates that do not equilibrate are strongly inhibited (α = 0.002 ± 0.003 for AcSCh (16); (α = 0.039 ± 0.002 for phenyl acetate 3 ). Values of α for Ac-homoSCh and Ac-norSCh of (0.16 and 0.26, Fig. 3) are the first we have found to fall in a mid-range that suggests partial rate determination by both k1 and k2.

Fig. 3.

Fig. 3

Inhibition of the enzymatic hydrolysis of (A) Ac-homoSCh and (B) Ac-norSCh by the P-site inhibitor thioflavin T. Initial experimental traces were analyzed with Eq. (1) to obtain values of kE +I and kE [I]=0. The initial [S]0 values were 10 μM, and [E]tot was 7.0 nM. The ratios kE [I]=0/kE +I were analyzed with Eq. (2) to obtain KI for thioflavin T and α. For Ac-homoSCh, KI = 1.33 ± 0.05 μM and α = 0.16 ± 0.01 (averages of 5 independent experiments). For Ac-norSCh, KI = 1.33 ± 0.08 μM and α = 0.26 ± 0.02 (averages of 2 independent experiments).

Partial rate determination implies that k1 and k2 would have comparable values in the expression for kE in Eq. (4), For both k1 and k2 to be partially rate-limiting steps in kE, k−1 and k2 in Eq. (5) must be approximately equal. Rearranging Eq. (5) and assuming from above that KS is about 1 mM, this approximate equality indicates that k1 can be only a little larger than kE. From the values of kE for Ac-homoSCh and Ac-norSCh in Table 1, the corresponding k1 these values would be 103 – 104 s−1. Such k1 values are one to two orders of magnitude lower than the minimum k1 calculated above for AcSCh. More precise estimates require application of non-equilibrium treatments to several converging kinetic and thermodynamic analyses of the interaction of these substrates with AChE, and such studies are in progress. It is unclear what feature of the P-site would control the magnitude of k1 and dictate preferential gating specificity for AcSCh relative to these two close analogs. But it seems clear that we can add substrate gating specificity to the list of functions played by the P-site in AChE.

Acknowledgments

This work was supported by grant NS-16577 from the National Institutes of Health and by contract HDTRA1-11-C-0017 from the Department of Defense

Abbreviations

A

absorbance

AChE

acetylcholinesterase

TcAChE

AChE from Torpedo californica

AcSCh

acetylthiocholine

Ac-homoSCh

acetyl(homo)thiocholine

Ac-norSCh

acetyl(nor)thiocholine

ATMA

3-(acetamido)-N,N,N-trimethylanilinium

BSA

bovine serum albumin

DTNB

5,5′-dithiobis-(2-nitrobenzoic acid)

norSCh

(nor)thiocholine

Footnotes

2

Throughout this paper we number amino acid residues according to the human AChE sequence unless otherwise noted.

3

V. Beri and T. L. Rosenberry, manuscript in preparation.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Changeux JP. Responses of acetylcholinesterase from Torpedo marmorata to salts and curarizing drugs. Mol Pharmacol. 1966;2:369–392. [PubMed] [Google Scholar]
  • 2.Taylor P, Lappi S. Interaction of fluorescence probes with acetylcholinesterase. The site and specificity of propidium binding. Biochemistry. 1975;14:1989–1997. doi: 10.1021/bi00680a029. [DOI] [PubMed] [Google Scholar]
  • 3.De Ferrari GV, Mallender WD, Inestrosa NC, Rosenberry TL. Thioflavin T is a fluorescent probe of the acetylcholinesterase peripheral site that reveals conformational interactions between the peripheral and acylation sites. J Biol Chem. 2001;276:23282–23287. doi: 10.1074/jbc.M009596200. [DOI] [PubMed] [Google Scholar]
  • 4.Rosenberry TL, Sonoda LK, Dekat SE, Cusack B, Johnson JL. Analysis of the reaction of carbachol with acetylcholinesterase using thioflavin T as a coupled fluorescence reporter. Biochemistry. 2008;47:13056–13063. doi: 10.1021/bi8015197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L, Silman I. Atomic structure of acetylcholinesterase from Torpedo californica: A prototypic acetylcholine-binding protein. Science. 1991;253:872–879. doi: 10.1126/science.1678899. [DOI] [PubMed] [Google Scholar]
  • 6.Harel M, Quinn DM, Nair HK, Silman I, Sussman JL. The X-ray structure of a transition state analog complex reveals the molecular origins of the catalytic power and substrate specificity of acetylcholinesterase. J Am Chem Soc. 1996;118:2340–2346. [Google Scholar]
  • 7.Harel M, Sonoda LK, Silman I, Sussman JL, Rosenberry TL. The crystal structure of thioflavin T bound to the peripheral site of Torpedo californica acetylcholinesterase reveals how thioflavin T acts as a sensitive fluorescent reporter of ligand binding to the acylation site. J Am Chem Soc. 2008;130:7856–7861. doi: 10.1021/ja7109822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Bourne Y, Taylor P, Radic Z, Marchot P. Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site. EMBO J. 2003;22:1–12. doi: 10.1093/emboj/cdg005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Harel M, Kleywegt GJ, Ravelli RBG, Silman I, Sussman JL. Crystal structure of an acetylcholinesterase-fasciculin complex: interaction of a three-fingered toxin from snake venom with its target. Structure. 1995;3:1355–1366. doi: 10.1016/s0969-2126(01)00273-8. [DOI] [PubMed] [Google Scholar]
  • 10.Bourne Y, Taylor P, Marchot P. Acetylcholinesterase inhibition by fasciculin: Crystal structure of the complex. Cell. 1995;83:503–512. doi: 10.1016/0092-8674(95)90128-0. [DOI] [PubMed] [Google Scholar]
  • 11.Tara S, Elcock AH, Kirchhoff PD, Briggs JM, Radic Z, Taylor P, McCammon JA. Rapid binding of a cationic active site inhibitor to wild type and mutant mouse acetylcholinesterase: Brownian dynamics simulation including diffusion in the active site gorge. Biopolymers. 1998;46:465–474. doi: 10.1002/(SICI)1097-0282(199812)46:7<465::AID-BIP4>3.0.CO;2-Y. [DOI] [PubMed] [Google Scholar]
  • 12.Szegletes T, Mallender WD, Thomas PJ, Rosenberry TL. Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis. Substrate inhibition arises as a secondary effect. Biochemistry. 1999;38:122–133. doi: 10.1021/bi9813577. [DOI] [PubMed] [Google Scholar]
  • 13.Mallender WD, Szegletes T, Rosenberry TL. Acetylthiocholine binds to Asp74 at the peripheral site of human acetylcholinesterase as the first step in the catalytic pathway. Biochemistry. 2000;39:7753–7763. doi: 10.1021/bi000210o. [DOI] [PubMed] [Google Scholar]
  • 14.Johnson JL, Cusack B, Davies MP, Fauq A, Rosenberry TL. Unmasking tandem site interaction in human acetylcholinesterase. Substrate activation with a cationic acetanilide substrate. Biochemistry. 2003;42:5438–5452. doi: 10.1021/bi027065u. [DOI] [PubMed] [Google Scholar]
  • 15.Mallender WD, Szegletes T, Rosenberry TL. Organophosphorylation of acetylcholinesterase in the presence of peripheral site ligands: Distinct effects of propidium and fasciculin. J Biol Chem. 1999;274:8491–8499. doi: 10.1074/jbc.274.13.8491. [DOI] [PubMed] [Google Scholar]
  • 16.Auletta JT, Johnson JL, Rosenberry TL. Molecular basis of inhibition of substrate hydrolysis by a ligand bound to the peripheral site of acetylcholinesterase. Chem Biol Interact. 2010;187:135–141. doi: 10.1016/j.cbi.2010.05.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Szegletes T, Mallender WD, Rosenberry TL. Nonequilibrium analysis alters the mechanistic interpretation of inhibition of acetylcholinesterase by peripheral site ligands. Biochemistry. 1998;37:4206–4216. doi: 10.1021/bi972158a. [DOI] [PubMed] [Google Scholar]
  • 18.Clery C, Bec N, Balny C, Mozhaev VV, Masson P. Kinetics of butyrylcholinesterase in reversed micelles under high pressure. Biochim Biophys Acta. 1995;1253:85–93. doi: 10.1016/0167-4838(95)00137-j. [DOI] [PubMed] [Google Scholar]
  • 19.Marcel V, Estrada-Mondaca S, Magné F, Stojan J, Klaébé A, Fournier D. Exploration of the Drosophila acetylcholinesterase substrate activation site using a reversible inhibitor (Triton X-100) and mutated enzymes. J Biol Chem. 2000;275:11603–11609. doi: 10.1074/jbc.275.16.11603. [DOI] [PubMed] [Google Scholar]
  • 20.White BJ, Andrew Legako JA, Harmon HJ. Extended lifetime of reagentless detector for multiple inhibitors of acetylcholinesterase. Biosensors and Bioelectronics. 2003;18:729–734. doi: 10.1016/s0956-5663(03)00042-3. [DOI] [PubMed] [Google Scholar]
  • 21.Quinn DM. Acetylcholinesterase: Enzyme structure, reaction dynamics, and virtual transition states. Chem Rev. 1987;87:955–979. [Google Scholar]
  • 22.Eastman J, Wilson EJ, Cervenansky C, Rosenberry TL. Fasciculin 2 binds to a peripheral site on acetylcholinesterase and inhibits substrate hydrolysis by slowing a step involving proton transfer during enzyme acylation. J Biol Chem. 1995;270:19694–19701. doi: 10.1074/jbc.270.34.19694. [DOI] [PubMed] [Google Scholar]
  • 23.Hofstee BHJ. On the evaluation of the constants Vm and KM in enzyme reactions. Science. 1952;116:329–331. doi: 10.1126/science.116.3013.329. [DOI] [PubMed] [Google Scholar]

RESOURCES